Weight Loss

Metformin/Glimepiride 850mg/4mg (extended release) is used to treat type 2 diabetes in adults, combining two blood sugar-lowering medications: metformin reduces glucose production, and glimepiride stimulates the pancreas to produce more insulin and improves its use. If discomfort persists, consult your doctor.

This combination of Metformin (850 mg) and Sitagliptin (50 mg) is a medication primarily indicated to improve blood sugar control in adult patients with type 2 diabetes mellitus. It serves the following specific purposes: Glycemic control: It is used in conjunction with diet and exercise when blood sugar is not adequately controlled with metformin alone or when the patient is already taking both medications separately. Dual mechanism of action: Metformin: Reduces glucose production in the liver and improves glucose sensitivity. If discomfort persists, consult your doctor.

This combination of Metformin (850 mg) and Sitagliptin (50 mg) is a medication primarily indicated to improve blood sugar control in adult patients with type 2 diabetes mellitus. It serves the following specific purposes: Glycemic control: It is used in conjunction with diet and exercise when blood sugar is not adequately controlled with metformin alone or when the patient is already taking both medications separately. Dual mechanism of action: Metformin: Reduces glucose production in the liver and improves glucose sensitivity. If discomfort persists, consult your doctor.

This combination of Metformin (850 mg) and Sitagliptin (50 mg) is a medication primarily indicated to improve blood sugar control in adult patients with type 2 diabetes mellitus. It serves the following specific purposes: Glycemic control: It is used in conjunction with diet and exercise when blood sugar is not adequately controlled with metformin alone or when the patient is already taking both medications separately. Dual mechanism of action: Metformin: Reduces glucose production in the liver and improves glucose sensitivity. If discomfort persists, consult your doctor.

The combination of Metformin/Vildagliptin (1000 mg/50 mg) is an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus in adults who do not achieve adequate control with maximum doses of metformin alone or who are already using both drugs separately. If discomfort persists, consult your doctor.

The combination of Metformin/Vildagliptin (1000 mg/50 mg) is an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus in adults who do not achieve adequate control with maximum doses of metformin alone or who are already using both drugs separately. If discomfort persists, consult your doctor.

It is indicated for the treatment of type 2 diabetes when glucose levels are not adequately controlled with metformin alone or in combination with other medications. The combination of its two active ingredients helps improve glycemic control in the following ways: Vildagliptin: It works by stimulating the pancreas to produce more insulin and less glucagon after meals. Metformin: It helps the body use insulin better and reduces glucose production by the liver. If discomfort persists, consult your doctor.

The combination of Metformin/Vildagliptin (1000 mg/50 mg) is an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus in adults who do not achieve adequate control with maximum doses of metformin alone or who are already using both drugs separately. If discomfort persists, consult your doctor.

Metformin 1000 mg, in a 40-tablet presentation, is a first-line antihyperglycemic medication primarily used for the treatment and control of type 2 diabetes mellitus. General Information Purpose: Helps lower blood glucose levels by decreasing sugar production in the liver and improving the sensitivity of cells to insulin. If discomfort persists, consult your doctor.

Metformin is indicated for the treatment of patients with type 2 diabetes mellitus (non-insulin-dependent diabetes), especially obese patients, in whom calorie restriction and physical activity are not sufficient to control glucose levels.

Metformin 750 mg in its 30-tablet extended-release presentation (often identified as XR or LP) is designed to release the medication gradually into the body over 24 hours, which usually improves digestive tolerance. If discomfort persists, consult your doctor.

Metformin 850 mg in a 30-tablet presentation is the standard dose for glycemic control in patients with type 2 diabetes. In Mexico (2025), it is one of the most accessible medications and has a wide variety of generic and brand-name options. If discomfort persists, consult your doctor.

Metformin 850 mg in a 30-tablet presentation is the standard dose for glycemic control in patients with type 2 diabetes. In Mexico (2025), it is one of the most accessible medications and has a wide variety of generic and brand-name options. If discomfort persists, consult your doctor.

Metformin helps your body control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from food and the amount of glucose synthesized by the liver. At the extrapancreatic level, glibenclamide reduces hepatic glucose production and enhances insulin action in peripheral tissues, primarily adipose and muscle tissue. It also has a mild diuretic effect and increases fluid clearance.

Metformin helps your body control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from food and the amount of glucose your liver synthesizes.

Metformin helps your body control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from food and the amount of glucose synthesized by the liver. At the extrapancreatic level, glibenclamide reduces hepatic glucose production and enhances insulin action in peripheral tissues, primarily adipose and muscle tissue. It also has a mild diuretic effect and increases fluid clearance.